Skip to main content
Erschienen in: Journal of General Internal Medicine 11/2019

19.07.2019 | Concise Research Reports

Trends in Prevalence of Nonalcoholic Fatty Liver Disease in US Adults with Prediabetes

verfasst von: Phuc Le, PhD, MPH, Alexander Chaitoff, MD, MPH, Michael B. Rothberg, MD, MPH, Naim Alkhouri, MD, Arthur McCullough, MD

Erschienen in: Journal of General Internal Medicine | Ausgabe 11/2019

Einloggen, um Zugang zu erhalten

Excerpt

Prediabetes affects 84 million US adults, more than 50% of whom will develop diabetes in 15 years.1 Once patients develop diabetes, up to 75% will have nonalcoholic fatty liver disease (NAFLD), and many of these will develop nonalcoholic steatohepatitis (NASH) and advanced fibrosis.2 However, the burden of NAFLD and associated comorbidities in patients with prediabetes is less well understood. We aimed to estimate the population-based trends in prevalence of concurrent suspected NAFLD, advanced fibrosis and NASH cirrhosis in US adults with prediabetes. …
Literatur
1.
Zurück zum Zitat Diabetes Prevention Program Research Group. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. Lancet Diabetes Endocrinol 2015;3(11):866–875.CrossRef Diabetes Prevention Program Research Group. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. Lancet Diabetes Endocrinol 2015;3(11):866–875.CrossRef
2.
Zurück zum Zitat Williams CD, Stengel J, Asike MI, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2011;140(1):124–131.CrossRef Williams CD, Stengel J, Asike MI, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2011;140(1):124–131.CrossRef
3.
Zurück zum Zitat Sviklane L, Olmane E, Dzerve Z, Kupcs K, Pirags V, Sokolovska J. Fatty liver index and hepatic steatosis index for prediction of non-alcoholic fatty liver disease in type 1 diabetes. J Gastroenterol Hepatol 2018;33(1):270–276.CrossRef Sviklane L, Olmane E, Dzerve Z, Kupcs K, Pirags V, Sokolovska J. Fatty liver index and hepatic steatosis index for prediction of non-alcoholic fatty liver disease in type 1 diabetes. J Gastroenterol Hepatol 2018;33(1):270–276.CrossRef
4.
Zurück zum Zitat Kabbany MN, Conjeevaram Selvakumar PK, Watt K, et al. Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data. Am J Gastroenterol 2017;112(4):581–587.CrossRef Kabbany MN, Conjeevaram Selvakumar PK, Watt K, et al. Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data. Am J Gastroenterol 2017;112(4):581–587.CrossRef
5.
Zurück zum Zitat Stefan N, Fritsche A, Schick F, Haring HU. Phenotypes of prediabetes and stratification of cardiometabolic risk. Lancet Diabetes Endocrinol 2016;4(9):789–798.CrossRef Stefan N, Fritsche A, Schick F, Haring HU. Phenotypes of prediabetes and stratification of cardiometabolic risk. Lancet Diabetes Endocrinol 2016;4(9):789–798.CrossRef
6.
Zurück zum Zitat Bae JC, Cho YK, Lee WY, et al. Impact of nonalcoholic fatty liver disease on insulin resistance in relation to HbA1c levels in nondiabetic subjects. Am J Gastroenterol 2010;105(11):2389–2395.CrossRef Bae JC, Cho YK, Lee WY, et al. Impact of nonalcoholic fatty liver disease on insulin resistance in relation to HbA1c levels in nondiabetic subjects. Am J Gastroenterol 2010;105(11):2389–2395.CrossRef
Metadaten
Titel
Trends in Prevalence of Nonalcoholic Fatty Liver Disease in US Adults with Prediabetes
verfasst von
Phuc Le, PhD, MPH
Alexander Chaitoff, MD, MPH
Michael B. Rothberg, MD, MPH
Naim Alkhouri, MD
Arthur McCullough, MD
Publikationsdatum
19.07.2019
Verlag
Springer US
Erschienen in
Journal of General Internal Medicine / Ausgabe 11/2019
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-019-05163-8

Weitere Artikel der Ausgabe 11/2019

Journal of General Internal Medicine 11/2019 Zur Ausgabe

Healing Arts

Good Night, Geese

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.